The effect of dexmedetomidine and ketamine on core body temperature changes in children under sedation during MRI

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250722066589N1

Enrollment

Registered

2025-07-31

Start date

2025-08-23

Completion date

Unknown

Last updated

2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The effect of dexmedetomidine and ketamine on core body temperature changes in children under sedation during MRI.

Interventions

Intervention 1: Intervention group: Dexmedetomidine. Intervention 2: Control group: ketamine.

Eligibility

Sex/Gender

All

Age

6 Months to 10 Years

Inclusion criteria

Inclusion criteria: Children aged 6 months to 10 years with ASA class I–II undergoing MRI under anesthesia at Mofid Hospital in the year 1404 (2025)

Exclusion criteria

Exclusion criteria: Allergy to intravenous anesthetics severe cardiac disease severe pulmonary disease increased intracranial pressure epilepsy initial body temperature of 37.5°C or higher signs of dehydration in the patient

Design outcomes

Primary

Measure	Time frame
The effect of dexmedetomidine and ketamine on body temperature changes in children under anesthesia during MRI imaging based on demographic variables. Timepoint: Before and after MRI. Method of measurement: Thermometer.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMalihe Abniki

Shahid Beheshti University of Medical Sciences

dr.abniki@sbmu.ac.ir+98 21 2271 8000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026